Dr. Nayeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8635 W 3rd St Suite 890W,
Los Angeles, CA 90048Phone+1 310-659-0715
Education & Training
- Vanderbilt University School of MedicineClass of 2016
Certifications & Licensure
- CA State Medical License 2018 - 2026
- FL State Medical License 2023 - 2026
- MN State Medical License 2023 - 2026
- MT State Medical License 2024 - 2026
- TX State Medical License 2024 - 2026
- WA State Medical License 2023 - 2026
- CO State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Publications & Presentations
PubMed
- Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence.Srikanth Krishnan, Pratyaksh K Srivastava, Jayram Attaluri, Rebecca Nayeri, Dhananjay Chatterjee
Journal of Cardiovascular Development and Disease. 2025-01-07 - 45 citationsImmune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.Jacqueline T Vuong, Ashley F Stein-Merlob, Arash Nayeri, Tamer Sallam, Tomas G Neilan
Journal of the American College of Cardiology. 2022-02-15 - 6 citationsVaping Instead of Cigarette Smoking: A Panacea or Just Another Form of Cardiovascular Risk?Arash Nayeri, Holly R. Middlekauff
The Canadian Journal of Cardiology. 2021-05-01
Press Mentions
- “Look Before You Leap:” Cardiologists Warn About the Risks of VapingApril 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: